JEFFREY MONK: Open Payments
NPI 1477282747 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,190 in 78 payments from 13 companies in 2025. Trend: 2023 $2,417 · 2024 $1,416 · 2025 $1,190
Food & beverage: $1,190
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 33 | $362 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $273 |
| Valinor Pharma, LLC | 7 | $116 |
| Averitas Pharma Inc. | 2 | $104 |
| Boston Scientific Corporation | 3 | $98 |
| PFIZER INC. | 3 | $67 |
| IBSA Pharma Inc. | 2 | $37 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Indivior Inc. | 2 | $28 |
| Foundation Fusion Solutions, LLC | 2 | $21 |
Products named: Belbuca, RELISTOR, MOVANTIK, QUTENZA, WaveWriter Alpha Prime 16, NURTEC ODT, Tirosint, HORIZANT.
Industry payments across PA — which companies pay providers there.
